2-amino-5-phosphonovalerate has been researched along with flunarizine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borowicz, K; Czuczwar, SJ; Gasior, M; Kleinrok, Z; Starownik, R | 1 |
| Brundin, P; Schierle, GS | 1 |
2 other study(ies) available for 2-amino-5-phosphonovalerate and flunarizine
| Article | Year |
|---|---|
Ca2+ channel blockade and the antielectroshock activity of NMDA receptor antagonists, CGP 40116 and CGP 43487, in mice.
Topics: 2-Amino-5-phosphonovalerate; Animals; Anticonvulsants; Calcium; Calcium Channel Blockers; Excitatory Amino Acid Antagonists; Flunarizine; Male; Mice; Nicardipine; Nifedipine; Receptors, N-Methyl-D-Aspartate | 1996 |
Excitotoxicity plays a role in the death of tyrosine hydroxylase- immunopositive nigral neurons cultured in serum-free medium.
Topics: 2-Amino-5-phosphonovalerate; Animals; Calcium Channel Blockers; Cell Death; Cell Survival; Cells, Cultured; Culture Media, Serum-Free; Dizocilpine Maleate; Embryo, Mammalian; Flunarizine; Mesencephalon; Neurons; Neurotoxins; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Kainic Acid; Receptors, N-Methyl-D-Aspartate; Tyrosine 3-Monooxygenase | 1999 |